Masuda S - Search Results

1

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.

Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Among authors: masuda s. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.

2

Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.

Fukudo M, Yano I, Masuda S, Fukatsu S, Katsura T, Ogura Y, Oike F, Takada Y, Tanaka K, Inui K. Fukudo M, et al. Among authors: masuda s. Clin Pharmacol Ther. 2005 Aug;78(2):168-81. doi: 10.1016/j.clpt.2005.04.008. Clin Pharmacol Ther. 2005. PMID: 16084851 Clinical Trial.

3

Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient.

Fukatsu S, Fukudo M, Masuda S, Yano I, Katsura T, Ogura Y, Oike F, Takada Y, Inui K. Fukatsu S, et al. Among authors: masuda s. Drug Metab Pharmacokinet. 2006 Apr;21(2):122-5. doi: 10.2133/dmpk.21.122. Drug Metab Pharmacokinet. 2006. PMID: 16702731 Free article.

4

Temporal decline in sirolimus elimination immediately after pancreatic islet transplantation.

Sato E, Shimomura M, Masuda S, Yano I, Katsura T, Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, Inui K. Sato E, et al. Among authors: masuda s. Drug Metab Pharmacokinet. 2006 Dec;21(6):492-500. doi: 10.2133/dmpk.21.492. Drug Metab Pharmacokinet. 2006. PMID: 17220565 Free article. Clinical Trial.

5

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.

Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K. Fukudo M, et al. Among authors: masuda s. Pharmacogenet Genomics. 2008 May;18(5):413-23. doi: 10.1097/FPC.0b013e3282f9ac01. Pharmacogenet Genomics. 2008. PMID: 18408564

6

Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.

Sato E, Yano I, Shimomura M, Masuda S, Katsura T, Matsumoto S, Okitsu T, Iwanaga Y, Uemoto S, Inui K. Sato E, et al. Among authors: masuda s. Drug Metab Pharmacokinet. 2009;24(2):175-9. doi: 10.2133/dmpk.24.175. Drug Metab Pharmacokinet. 2009. PMID: 19430174 Free article.

7

Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study.

Hosohata K, Masuda S, Yonezawa A, Sugimoto M, Takada Y, Kaido T, Ogura Y, Oike F, Uemoto S, Inui K. Hosohata K, et al. Among authors: masuda s. Drug Metab Pharmacokinet. 2009;24(5):458-63. doi: 10.2133/dmpk.24.458. Drug Metab Pharmacokinet. 2009. PMID: 19881258 Free article.

8

Developmental trajectory of intestinal MDR1/ABCB1 mRNA expression in children.

Mizuno T, Fukuda T, Masuda S, Uemoto S, Matsubara K, Inui K, Vinks AA. Mizuno T, et al. Among authors: masuda s. Br J Clin Pharmacol. 2014 May;77(5):910-2. doi: 10.1111/bcp.12211. Br J Clin Pharmacol. 2014. PMID: 23879365 Free PMC article. No abstract available.

9

Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.

Hosohata K, Uesugi M, Hashi S, Hosokawa M, Inui K, Matsubara K, Ogawa K, Fujimoto Y, Kaido T, Uemoto S, Masuda S. Hosohata K, et al. Among authors: masuda s. Drug Metab Pharmacokinet. 2014;29(1):83-9. doi: 10.2133/dmpk.dmpk-13-rg-060. Epub 2013 Aug 13. Drug Metab Pharmacokinet. 2014. PMID: 23955548 Free article.

10

Therapeutic Drug Monitoring of Everolimus: A Consensus Report.

Shipkova M, Hesselink DA, Holt DW, Billaud EM, van Gelder T, Kunicki PK, Brunet M, Budde K, Barten MJ, De Simone P, Wieland E, López OM, Masuda S, Seger C, Picard N, Oellerich M, Langman LJ, Wallemacq P, Morris RG, Thompson C, Marquet P. Shipkova M, et al. Among authors: masuda s. Ther Drug Monit. 2016 Apr;38(2):143-69. doi: 10.1097/FTD.0000000000000260. Ther Drug Monit. 2016. PMID: 26982492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,934 results

Search Page